ReviewScience advances2025
Stereospecific cross-coupling reactions: Programmed assembly of chiral molecules by reaction of chiral reagents.
Review in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Iron-Catalyzed Dealkenylative Borylation of Alkenes via Ozonolysis.Journal of the American Chemical Society · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Long recognized as being a challenge in the arena of cross-coupling reactions, the formation of C-C bonds between saturated carbon centers has become simpler because of advances in catalyst design. However, when these processes involve the reaction of chiral carbon centers, the control of reaction stereochemistry remains a pressing concern. One still-emerging strategy for stereocontrol in cross-coupling relies on construction of configurationally defined reactants paired with catalysts that transform these substrates with high stereochemical fidelity. In this review, we survey chiral organometallic reagents that may be formed with enantiocontrol and examine advances in their cross-coupling.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.